In AKI, the activation of MAPK1 was likely a consequence of the kidney’s response to injury, promoting the release of pro-inflammatory mediators and contributing to renal damage (Ajay et al., 2024; Wang et al., 2023). The gene discussed is MAPK1; the disease is acute kidney injury.